Indaptus Therapeutics INDP Income Statement (2020-2026)

NASDAQ INDP
$1.38 +0.44 (+46.81%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & Development (Quarter)
0.70M0.94M1.30M1.51M1.61M1.91M1.88M1.48M2.23M2.03M1.59M1.71M1.47M2.48M2.81M2.17M1.52M2.85M0.49M0.36M
Selling, General & Administrative (Quarter)
2.67M2.27M2.10M2.36M1.94M2.18M2.58M2.01M2.02M2.15M2.35M2.39M1.68M1.69M1.76M2.29M1.13M5.31M1.67M1.45M
Other Operating Expenses (Quarter)
0.14M0.09M0.07M0.04M0.04M0.02M0.04M0.04M
Operating Expenses (Quarter)
3.37M3.22M3.40M3.87M3.55M4.09M4.46M3.50M4.25M4.18M3.94M4.11M3.14M4.17M4.57M4.46M2.65M8.16M2.16M1.81M
Operating Income (Quarter)
-3.37M-3.22M-3.40M-3.87M-3.55M-4.09M-4.46M-3.50M-4.25M-4.18M-3.94M-4.11M-3.14M-4.17M-4.57M-4.46M-2.65M-8.16M-2.16M-1.81M
EBIT (Quarter)
-3.37M-3.22M-3.40M-3.87M-3.55M-4.09M-4.46M-3.50M-4.25M-4.18M-3.94M-4.11M-3.14M-4.17M-4.57M-4.46M-2.65M-8.16M-2.16M-1.81M
Non-operating items
Non Operating Investment Income (Quarter)
0.01M0.10M0.13M0.16M0.14M
Interest & Investment Income (Quarter)
-0.01M-0.02M0.05M0.18M0.21M0.12M0.01M
Other Non Operating Income (Quarter)
0.09M0.07M0.04M0.04M0.02M0.04M0.04M0.03M0.01M
Non Operating Income (Quarter)
827.000.00M0.04M0.03M0.09M0.43M0.20M0.25M0.33M0.18M0.14M0.09M0.07M0.04M0.04M
Net income details
EBT (Quarter)
-4.39M-3.24M-3.51M-4.02M-3.51M-3.93M-4.27M-3.62M-4.80M-4.20M-4.36M-4.42M-3.25M-4.20M-4.60M-5.26M-2.66M-8.18M-2.22M-1.84M
Tax Provisions (Quarter)
Profit After Tax (Quarter)
-3.37M-3.22M-3.37M-3.84M-3.42M-3.57M-4.25M-3.25M-3.92M-4.00M-3.81M-4.02M-3.07M-4.13M-4.53M-5.23M-2.98M-8.11M-2.54M-1.79M
Income from Non-Controlling Interests (Quarter)
-0.01M-0.02M0.05M0.18M0.21M0.12M
Income from Continuing Operations (Quarter)
-4.39M-3.24M-3.51M-4.02M-3.51M-3.93M-4.27M-3.62M-4.80M-4.20M-4.36M-4.42M-3.25M-4.20M-4.60M-5.26M-2.66M-8.18M-2.22M-1.84M
Consolidated Net Income (Quarter)
-4.39M-3.24M-3.51M-4.02M-3.51M-3.93M-4.27M-3.62M-4.80M-4.20M-4.36M-4.42M-3.25M-4.20M-4.60M-5.26M-2.66M-8.18M-2.22M-1.84M
Income towards Parent Company (Quarter)
-4.39M-3.24M-3.51M-4.02M-3.51M-3.93M-4.27M-3.62M-4.80M-4.20M-4.36M-4.42M-3.25M-4.20M-4.60M-5.26M-2.66M-8.18M-2.22M-1.84M
Net Income towards Common Stockholders (Quarter)
-4.39M-3.24M-3.51M-4.02M-3.51M-3.93M-4.27M-3.62M-4.80M-4.20M-4.36M-4.42M-3.25M-4.20M-4.60M-5.26M-2.66M-8.18M-2.22M-1.84M
Additional items
EPS (Basic) (Quarter)
-29.43-22.19-11.90-13.62-11.89-13.31-14.23-12.05-16.00-14.02-14.46-14.48-9.58-12.56-9.13-9.14-2.67-8.47-0.20-0.02
EPS (Diluted) (Quarter)
-13.62-11.89-13.31-14.23-12.05-16.00-14.02-14.46-14.48-9.58-12.56-9.13-9.14-2.67-8.47-0.20-0.02
Shares Outstanding (Quarter)
0.15M0.15M0.29M0.29M0.29M0.30M0.30M0.30M0.30M0.30M0.30M0.31M0.34M0.33M0.50M0.57M1.00M0.97M10.96M116.13M
Shares Outstanding (Diluted) (Quarter)
0.29M0.29M0.30M0.30M0.30M0.30M0.30M0.30M0.31M0.34M0.33M0.50M0.57M1.00M0.97M10.96M116.13M
Shares Outstanding (Entity) (Quarter)
0.15M0.15M0.29M0.29M0.29M0.30M0.30M0.30M0.30M0.30M0.30M0.31M0.36M0.33M0.57M0.60M1.00M0.97M10.96M133.24M
EBITDA (Quarter)
-3.37M-3.22M-3.40M-3.87M-3.55M-4.09M-4.46M-3.50M-4.25M-4.18M-3.94M-4.11M-3.14M-4.17M-4.57M-4.46M-2.65M-8.16M-2.16M-1.81M
Interest Expenses (Quarter)
1.03M0.02M0.10M0.13M0.00M0.02M0.02M0.24M0.56M0.03M0.42M0.31M0.11M0.03M0.03M0.80M0.01M0.02M0.06M0.03M
Tax Rate (Quarter)